The city of St Louis, Missouri, currently has 1 active clinical trials seeking participants for Lymphoma research studies.
A Study of Glofitamab and Lenalidomide in People with Mantle Cell Lymphoma
Recruiting
The purpose of this study is to find out whether the combination of glofitamab and lenalidomide is an effective treatment for relapsed or refractory Mantle Cell Lymphoma
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/14/2025
Locations: Washington University (Data Collection Only), St Louis, Missouri
Conditions: Mantle Cell Lymphoma, MCL